Co-Authors
This is a "connection" page, showing publications co-authored by Mariangela Manfredi and Francesca Li Gobbi.
Connection Strength
1.289
-
COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patients. J Med Virol. 2020 11; 92(11):2368-2370.
Score: 0.444
-
Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al. Ann Rheum Dis. 2020 Aug 04.
Score: 0.224
-
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 Jul 06.
Score: 0.223
-
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020 04; 22(4):203-210.
Score: 0.219
-
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e166.
Score: 0.060
-
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab. Immunol Res. 2021 08; 69(4):309-311.
Score: 0.060
-
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations. Autoimmun Rev. 2021 10; 20(10):102908.
Score: 0.060